Restart Life Sciences Corp.
HEAL
CNSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -983.60K | -870.70K | -380.60K | -299.70K | 163.70K |
| Total Depreciation and Amortization | 1.20K | 1.30K | 1.40K | 1.50K | 1.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 661.20K | 485.60K | 31.80K | -3.10K | -422.40K |
| Change in Net Operating Assets | -189.70K | 98.30K | 115.90K | 118.80K | 204.10K |
| Cash from Operations | -510.80K | -285.40K | -231.40K | -182.40K | -52.80K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 250.00K | 15.00K | 15.00K | 15.00K | 75.00K |
| Total Debt Repaid | -83.00K | -83.00K | -83.00K | -83.00K | -- |
| Issuance of Common Stock | 2.14M | 550.00K | 550.00K | 550.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.64M | 336.10K | 336.10K | 336.10K | 55.20K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.13M | 50.60K | 104.60K | 153.60K | 2.40K |